#CannesLions2022: Pharma and health marketers lose spotlight at creativity ad fest, but does it matter?

Beth Snyder Bulik

Senior Editor

Nicole DeFeudis

Editor

Pharma advertising has long been considered second-tier when compared to the rest of the advertising industry. And there are some legitimate reasons why. Nike sneakers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#CannesLions2022: Pharma and health marketers lose spotlight at creativity ad fest, but does it matter?

Beth Snyder Bulik

Senior Editor

Nicole DeFeudis

Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

#Can­nes­Lions2022: Phar­ma and health mar­keters lose spot­light at cre­ativ­i­ty ad fest, but does it mat­ter?

Senior Editor

Editor

Sign up to read this article for free.

#CannesLions2022: Pharma and health marketers lose spotlight at creativity ad fest, but does it matter?